Literature DB >> 20527782

Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery.

Udaya S Toti1, Bharath Raja Guru, Alex E Grill, Jayanth Panyam.   

Abstract

Nanoparticles formulated using poly(d,l-lactide-co-glycolide) (PLGA) copolymer have emerged as promising carriers for targeted delivery of a wide variety of payloads. However, an important drawback with PLGA nanoparticles is the limited types of functional groups available on the surface for conjugation to targeting ligands. In the current report, we demonstrate that the interfacial activity assisted surface functionalization (IAASF) technique can be used to incorporate reactive functional groups such as maleimide onto the surface of PLGA nanoparticles. The surface maleimide groups were used to conjugate cRGD peptide to nanoparticles. The cRGD peptide targets alpha(v)beta(3) integrins overexpressed on tumor vasculature and some tumor cells, and was used as model targeting ligand in this study. Incorporation of biologically active cRGD peptide on the surface of nanoparticles was confirmed by in vitro cell uptake studies and in vivo tumor accumulation studies. Functionalization of nanoparticles with cRGD peptide increased the cellular uptake of nanoparticles 2-3-fold, and this enhancement in uptake was substantially reduced by the presence of excess cRGD molecules. In a syngeneic mouse 4T1 tumor model, cRGD functionalization resulted in increased accumulation and retention of nanoparticles in the tumor tissue (nearly 2-fold greater area under the curve), confirming the in vivo activity of cRGD functionalized nanoparticles. In conclusion, the IAASF technique enabled the incorporation of reactive maleimide groups on PLGA nanoparticles, which in turn permitted efficient conjugation of biologically active cRGD peptide to the surface of PLGA nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20527782      PMCID: PMC2914136          DOI: 10.1021/mp900284c

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  34 in total

1.  Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles.

Authors:  Jayanth Panyam; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2004-01-12       Impact factor: 4.939

2.  In vitro evaluation of biodegradable microspheres with surface-bound ligands.

Authors:  Mark E Keegan; Sara M Royce; Tarek Fahmy; W Mark Saltzman
Journal:  J Control Release       Date:  2005-12-28       Impact factor: 9.776

3.  Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.

Authors:  Paul A McCarron; Waleed M Marouf; Ryan F Donnelly; Chris Scott
Journal:  J Biomed Mater Res A       Date:  2008-12-15       Impact factor: 4.396

Review 4.  Engineering biodegradable polyester particles with specific drug targeting and drug release properties.

Authors:  Farahidah Mohamed; Christopher F van der Walle
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

5.  Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.

Authors:  Norased Nasongkla; Erik Bey; Jimin Ren; Hua Ai; Chalermchai Khemtong; Jagadeesh Setti Guthi; Shook-Fong Chin; A Dean Sherry; David A Boothman; Jinming Gao
Journal:  Nano Lett       Date:  2006-11       Impact factor: 11.189

6.  Expression of alphav integrins and vitronectin receptor identity in breast cancer cells.

Authors:  T Meyer; J F Marshall; I R Hart
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

7.  Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

Authors:  Changyou Zhan; Bing Gu; Cao Xie; Jin Li; Yu Liu; Weiyue Lu
Journal:  J Control Release       Date:  2010-01-07       Impact factor: 9.776

8.  Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.

Authors:  Bingfeng Sun; Balu Ranganathan; Si-Shen Feng
Journal:  Biomaterials       Date:  2007-10-22       Impact factor: 12.479

9.  UEA I-bearing nanoparticles for brain delivery following intranasal administration.

Authors:  Xiaoling Gao; Jun Chen; Weixing Tao; Jianhua Zhu; Qizhi Zhang; Hongzhuan Chen; Xinguo Jiang
Journal:  Int J Pharm       Date:  2007-03-30       Impact factor: 5.875

10.  Application of nanotechnology in cancer therapy and imaging.

Authors:  Xu Wang; Lily Yang; Zhuo Georgia Chen; Dong M Shin
Journal:  CA Cancer J Clin       Date:  2008-01-28       Impact factor: 508.702

View more
  12 in total

1.  Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infection.

Authors:  Shailendra B Tallapaka; Bala V K Karuturi; Pravin Yeapuri; Stephen M Curran; Yogesh A Sonawane; Joy A Phillips; D David Smith; Sam D Sanderson; Joseph A Vetro
Journal:  Int J Pharm       Date:  2019-05-08       Impact factor: 5.875

2.  Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy.

Authors:  Avinash Srivatsan; Manivannan Ethirajan; Suresh K Pandey; Shipra Dubey; Xiang Zheng; Ting-Hsiu Liu; Masayuki Shibata; Joseph Missert; Janet Morgan; Ravindra K Pandey
Journal:  Mol Pharm       Date:  2011-07-01       Impact factor: 4.939

3.  Preparation of particulate polymeric therapeutics for medical applications.

Authors:  Jia Zhuang; Ronnie H Fang; Liangfang Zhang
Journal:  Small Methods       Date:  2017-07-25

4.  Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine.

Authors:  Ameya R Kirtane; Tanmoy Sadhukha; Hyunjoon Kim; Vidhi Khanna; Brenda Koniar; Jayanth Panyam
Journal:  Cancer Res       Date:  2017-01-20       Impact factor: 12.701

5.  Aptamer-labeled PLGA nanoparticles for targeting cancer cells.

Authors:  Athulya Aravind; Saino Hanna Varghese; Srivani Veeranarayanan; Anila Mathew; Yutaka Nagaoka; Seiki Iwai; Takahiro Fukuda; Takashi Hasumura; Yasuhiko Yoshida; Toru Maekawa; D Sakthi Kumar
Journal:  Cancer Nanotechnol       Date:  2012-01-19

6.  Reformulating Tylocrebrine in Epidermal Growth Factor Receptor Targeted Polymeric Nanoparticles Improves Its Therapeutic Index.

Authors:  Ameya R Kirtane; Henry L Wong; Bharath Raja Guru; Lev G Lis; Gunda I Georg; Vadim J Gurvich; Jayanth Panyam
Journal:  Mol Pharm       Date:  2015-07-03       Impact factor: 4.939

7.  Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.

Authors:  Mingzhen Zhang; Changlong Xu; Dandan Liu; Moon Kwon Han; Lixin Wang; Didier Merlin
Journal:  J Crohns Colitis       Date:  2018-01-24       Impact factor: 9.071

Review 8.  Concepts and practices used to develop functional PLGA-based nanoparticulate systems.

Authors:  Hongkee Sah; Laura A Thoma; Hari R Desu; Edel Sah; George C Wood
Journal:  Int J Nanomedicine       Date:  2013-02-21

9.  Macrophage-Biomimetic Nanoparticles Ameliorate Ulcerative Colitis through Reducing Inflammatory Factors Expression.

Authors:  Zhengshuo Li; Xiaoyue Zhang; Can Liu; Qiu Peng; Yangge Wu; Yuqing Wen; Run Zheng; Qun Yan; Jian Ma
Journal:  J Innate Immun       Date:  2021-11-01       Impact factor: 7.111

10.  Application of an assay Cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas.

Authors:  Cristina Fornaguera; Miguel Ángel Lázaro; Pau Brugada-Vilà; Irene Porcar; Ingrid Morera; Marta Guerra-Rebollo; Cristina Garrido; Núria Rubio; Jerónimo Blanco; Anna Cascante; Salvador Borrós
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.